Pioneering Medical Innovations
Ocular Therapeutix, Inc. announced today that it has closed a $14 million Series D round of financing. The round was
Agreement creates opportunity for improving outcomes in radiation oncology PALO ALTO, Calif. and WALTHAM, Mass., May 12, 2011 /PRNewswire/ —
WALTHAM, Mass., Oct. 16 /PRNewswire/ — Augmenix announced today that it has closed a $6.1 million Series B financing. The
I-Therapeutix announced today that it has closed a $15million dollar Series C financing. The round was led by Polaris Venture